Charcot-Marie-Tooth Disease Type 2 Caused by Mutation in the GARS1 Gene (CMT2D)

Charcot-Marie-Tooth disease type 2 caused by mutation in the GARS1 gene (often called CMT2D) is a rare, inherited nerve disease. It mainly damages the long nerves that control movement and feeling in the hands and feet. This type is “axonal,” which means the inner cable of the nerve (the axon) slowly dies, rather than the insulating myelin being the main problem. Symptoms usually start in the teenage years or early adult life with weakness and wasting of the small muscles of the hands and feet, reduced reflexes, and problems with balance and walking. NCBI+1

Charcot-Marie-Tooth disease type 2 caused by mutation in the GARS gene is a rare inherited nerve disease that damages the long nerves in the arms and legs. Doctors often call it GARS1-associated axonal neuropathy or CMT2D. It usually starts in teenage years or young adult life and mainly affects the small muscles of the hands and feet. People may notice hand weakness, trouble writing or buttoning clothes, foot drop, high-arched feet, and slowly increasing difficulty with walking and balance.NCBI+1

In this condition, the GARS1 gene, which gives instructions to make an enzyme called glycyl-tRNA synthetase, is changed by a mutation. This enzyme is very important for building proteins inside nerve cells. The mutation makes the enzyme work in an abnormal way, which hurts the long axons of peripheral nerves. Over time, the nerve fibers become thinner and weaker, and they cannot carry signals properly to muscles and from the skin. This leads to muscle wasting, weakness, and loss of feeling in the hands and feet.NCBI+1

This condition is caused by harmful changes (pathogenic variants) in the GARS1 gene, which is found on chromosome 7. The GARS1 gene gives instructions to make an enzyme called glycyl-tRNA synthetase (GlyRS). This enzyme is essential for normal protein building in every cell of the body. In this disease, the mutation makes the enzyme behave in an abnormal way inside nerve cells, especially in the long motor nerves that go to the hands and feet. Over time, this leads to slow but progressive loss of nerve fibers, muscle weakness, and disability. NCBI+1

Other names

Charcot-Marie-Tooth disease type 2 caused by GARS1 mutation has several other names in medical books and databases. One common name is Charcot-Marie-Tooth neuropathy type 2D (CMT2D), which identifies it as a type 2 (axonal) form with a specific genetic cause. Another very close condition caused by the same gene changes is distal hereditary motor neuropathy type V (dHMN-V), in which motor weakness is present but sensory loss may be mild or absent. Today, experts often group both CMT2D and dHMN-V together under the broader term “GARS1-associated axonal neuropathy” or GARS1-HMSN (hereditary motor and sensory neuropathy). NCBI+2Monarch Initiative+2

Types of GARS-related Charcot-Marie-Tooth disease

Doctors do not divide GARS-related CMT into many numbered types, but they do describe a clinical spectrum. At one end of the spectrum is CMT2D, in which both motor and sensory nerves are affected. At the other end is distal hereditary motor neuropathy type V, where weakness and wasting of the small hand muscles are the main issues, and sensory loss is mild or hard to detect. These patterns are caused by different GARS1 variants and by how strongly sensory neurons are involved in each person. NCBI+2Wiley Online Library+2

Doctors also talk about age-of-onset types, such as infant-onset, adolescent-onset, and adult-onset GARS1 neuropathy. Early-onset forms may show more severe weakness and delay in motor milestones, while adolescent or adult-onset forms usually show slowly progressive weakness that starts in the hands and later involves the feet and legs. These differences show that the same gene can cause a wide range of disease severity in different people or families. NCBI+1

Causes and mechanisms

1. Pathogenic GARS1 gene mutation
   The main and direct cause of this disease is a harmful change in one copy of the GARS1 gene. This change is usually a missense mutation, which means a single “letter” in the DNA code is altered so that a different amino acid is placed in the enzyme. This single change is enough to disturb nerve function and lead to CMT2D. PLOS+1

2. Autosomal dominant inheritance
   GARS-related CMT2D is usually inherited in an autosomal dominant pattern. This means a person needs only one mutated copy of the gene, from either mother or father, to develop the condition. Each child of an affected parent has a 50% chance of inheriting the mutation and being at risk for the disease. NCBI+1

3. De novo (new) mutations
   Sometimes the GARS1 mutation appears for the first time in a child, even though both parents have normal genes. This is called a de novo mutation. In such families, there is no previous history of CMT, but the child can later pass the mutation on to his or her own children. NCBI+1

4. Toxic gain-of-function of mutant GlyRS
   Research suggests that the GARS1 mutations cause disease not only by losing normal function but also by gaining a harmful new function. The mutant GlyRS enzyme binds to wrong partners in the cell, leading to toxic effects in motor neurons. This is called a toxic gain-of-function mechanism and is a key cause of nerve cell damage. PLOS+1

5. Partial loss of normal GlyRS activity
   At the same time, some mutations reduce the normal enzymatic activity of GlyRS. When the enzyme does not work properly, the cell cannot attach glycine to its tRNA efficiently, which disturbs protein production. This partial loss of normal function can stress neurons and make long axons especially vulnerable. PLOS+1

6. Impaired aminoacylation of tRNA-glycine
   GlyRS normally attaches glycine to its specific tRNA during the first steps of protein synthesis. Mutant GlyRS can fail to correctly “charge” tRNA with glycine, which slows or stalls the building of many proteins. This problem is particularly damaging in neurons, which need constant protein synthesis to maintain long axons. PLOS+1

7. Disrupted local protein synthesis in axons
   Nerve axons rely on protein synthesis that happens locally near the synapse. When GARS1 function is abnormal, local protein production in axons is disturbed. Over time, this leads to structural weakness of the axon, with thinning, swelling, and eventual degeneration, especially in the longest nerves going to hands and feet. Wikipedia+1

8. Abnormal interaction with VEGF / neuropilin-1 pathway
   Mutant GlyRS can bind to cell-surface receptors such as neuropilin-1 and interfere with signaling by vascular endothelial growth factor (VEGF). This abnormal binding blocks normal protective signals for motor neurons and may be a major cause of the selective motor neuron damage seen in CMT2D. Wikipedia+1

9. Selective vulnerability of motor neurons
   For reasons not fully understood, motor neurons that control hand and foot muscles seem more sensitive to GARS1 mutations than other cells. Their extreme length, high metabolic demand, and complex synapses make them more likely to suffer from subtle defects in protein synthesis and signaling, leading to weakness and wasting. NCBI+1

10. Sensory neuron involvement in some patients
    In some people, sensory neurons are also damaged, causing numbness or altered sensation. When sensory axons are involved along with motor axons, the condition is labeled CMT2D rather than pure motor neuropathy. This variability shows that damage to both sensory and motor neurons is another important cause of symptoms. NCBI+1

11. Distal axonal degeneration (“dying-back” neuropathy)
    The disease often follows a “dying-back” pattern: the far ends of the longest axons degenerate first, then damage slowly creeps closer to the body. This type of degeneration is a direct result of long-term transport and energy problems inside the axon, which are triggered by the mutated GARS1 enzyme. Europe PMC+1

12. Mitochondrial and energy stress
    Long axons rely heavily on healthy mitochondria to supply energy. When protein synthesis and signaling are disturbed by mutant GlyRS, mitochondria may not work at their best. Low energy in distal axons makes them more likely to degenerate, adding another layer to the cause of the neuropathy. Wikipedia+1

13. Endoplasmic reticulum (ER) stress and integrated stress response
    Studies show that some GARS1 mutations can cause ribosomes to stall and activate cellular stress pathways called the integrated stress response. This ER-related stress can push vulnerable neurons toward dysfunction and death, and is considered an important part of the disease mechanism. Wikipedia+1

14. Genetic modifiers in other genes
    Some people with the same GARS1 mutation have milder or more severe disease than others. This suggests that changes in other genes, called genetic modifiers, can soften or worsen the effect of the main mutation. These modifiers do not cause the disease alone but influence how strongly it appears. NCBI+1

15. Age-related neuronal wear and tear
    As people age, axons naturally face more wear and tear. In someone who already has a GARS1 mutation, this age-related stress can accelerate symptoms. This is one reason why some people may not show clear weakness until adolescence or adulthood, even though the gene change is present from birth. Europe PMC+1

16. Co-existing metabolic or nutritional problems
    Conditions such as diabetes, thyroid disease, or vitamin B12 deficiency can cause their own neuropathies. If a person with GARS1-related CMT develops one of these problems, the combined damage can make symptoms worse and appear earlier, even though these conditions do not cause the original gene mutation. Europe PMC+1

17. Neurotoxic medications or alcohol exposure
    Certain chemotherapy drugs, heavy alcohol use, or other neurotoxic substances can harm peripheral nerves. In a person with a GARS1 mutation, these exposures can unmask or speed up neuropathy, acting as additional causes of nerve damage on top of the inherited disease. Europe PMC+1

18. Repetitive mechanical stress on feet and hands
    Repeated pressure, poorly fitting shoes, or heavy physical strain on the feet and hands do not cause the genetic disease, but they can worsen symptoms. Weak muscles and unstable joints are more easily injured, so repeated mechanical stress can lead to earlier deformities and pain. Wikipedia+1

19. Delayed diagnosis and lack of supportive care
    When the condition is not recognized early, people may not receive braces, physiotherapy, or lifestyle advice. Without these supports, the natural course of axonal degeneration can cause more marked muscle wasting and contractures, making the inherited cause more disabling in daily life. Europe PMC+1

20. Random biological variation (variable expressivity)
    Even in the same family, some people with the mutation may have mild weakness, while others have more severe symptoms. This natural randomness in biological processes, called variable expressivity, means the same genetic cause can look very different from one person to another. NCBI+1

Symptoms and clinical features

1. Distal hand weakness
   One of the most typical symptoms of GARS-related CMT2D is weakness in the small muscles of the hands. People often notice difficulty with fine movements, such as turning keys, opening jars, or lifting small objects. Over time, the thumb muscles can waste, and grip strength is noticeably reduced. NCBI+1

2. Difficulty with pinch and finger movements
   Because specific hand muscles are affected, tasks that need accurate pinch between thumb and fingers become hard. Patients may struggle to button clothes, handle coins, or use a pen. This difficulty often appears before major problems in the feet, which is somewhat unique compared with many other types of CMT. NCBI+1

3. Foot weakness and foot drop
   As the disease progresses, weakness usually appears in the muscles that lift the foot and toes. This leads to “foot drop,” where the toes drag when walking. People may trip on carpets, small steps, or uneven ground and may adapt by lifting their knees higher in a “steppage gait.” Wikipedia+1

4. High-arched feet (pes cavus)
   Long-standing weakness and imbalance between different foot muscles can cause a high-arched foot with clawed toes, known as pes cavus. This deformity puts extra pressure on the ball and heel of the foot, causing calluses, pain, and difficulty finding comfortable shoes. Wikipedia+1

5. Hammertoes and toe deformities
   Weakness and tightness in small foot muscles can pull the toes into bent positions called hammertoes. These toe deformities may rub against shoes, causing blisters or ulcers. They are a visible sign of chronic motor nerve damage in CMT2D and related neuropathies. Wikipedia+1

6. Muscle wasting in hands and feet
   Over time, the muscles in the hands and lower legs become thinner and smaller, a process known as atrophy. The hands may look “hollow” between the thumb and index finger, and the calves can look skinny compared with the thighs. This muscle loss is due to long-term denervation from damaged motor axons. NCBI+1

7. Numbness or reduced sensation
   In many people with CMT2D, sensory nerves are also affected. They may notice numbness, tingling, or reduced feeling in the toes and fingers. This loss of sensation may be mild but can still increase the risk of unnoticed injuries, such as small cuts or burns, especially in the feet. NCBI+1

8. Neuropathic pain or discomfort
   Some patients experience burning, stabbing, or electric-shock-like pain in the feet or hands, which doctors call neuropathic pain. Even when pain is mild, it can disturb sleep and reduce quality of life. This pain comes from irritated or damaged nerve fibers sending abnormal signals to the brain. Europe PMC+1

9. Reduced or absent tendon reflexes
   On examination, doctors often find that ankle and sometimes knee reflexes are weak or absent. Reflex hammers may show little reaction when tapping the Achilles tendon. In GARS-related neuropathy the upper limb reflexes can also be reduced, fitting with the pattern of motor nerve involvement in arms and legs. MalaCards+1

10. Balance problems and unsteady gait
    Weak muscles and poor sensation in the feet make it hard to feel the ground and to control posture. People may sway when standing, especially with eyes closed, and may feel unsafe walking in the dark or on uneven surfaces. This unsteadiness increases the risk of falls. Wikipedia+1

11. Frequent tripping and falls
    Foot drop, poor balance, and toe deformities together make tripping more likely. Patients may report many small falls or stumbles each month. This symptom is not only uncomfortable but also important for doctors to assess, because frequent falls can lead to fractures and long-term disability. Wikipedia+1

12. Hand clumsiness and difficulty with fine motor tasks
    As hand weakness progresses, writing, using a smartphone, typing, or playing musical instruments may become difficult. People may describe their hands as clumsy or slow. This problem can affect education, work, and hobbies and is a major functional impact of GARS-related neuropathy. NCBI+1

13. Muscle cramps and fatigue
    Damaged nerves can cause muscles to cramp or twitch, especially after prolonged standing or walking. Many patients also feel that their legs and hands tire quickly. This fatigue comes from having fewer working motor units, so the remaining ones must work harder to perform everyday activities. Europe PMC+1

14. Mild skeletal deformities (such as scoliosis)
    In some inherited neuropathies, including certain CMT forms, long-term imbalance of muscles around the spine and chest can contribute to curvature of the spine (scoliosis). While not universal in CMT2D, mild trunk deformities can appear, especially when onset is in childhood or adolescence. Wikipedia+1

15. Psychosocial impact and reduced quality of life
    The visible deformities, hand and foot weakness, and chronic symptoms can affect mood, self-confidence, and social participation. People may feel anxious about walking, embarrassed about their feet, or worried about career choices. This emotional impact is an important part of the overall symptom burden. Europe PMC+1

Diagnostic tests

Physical examination

1. Comprehensive neurological examination
   A neurologist first performs a full neurological exam, checking muscle strength, tone, reflexes, sensation, and coordination. In GARS-related CMT2D, this exam often shows distal weakness in hands and feet, reduced reflexes, and mild sensory loss. The pattern of findings helps distinguish hereditary neuropathy from other nerve or muscle diseases. Europe PMC+1

2. Musculoskeletal and foot examination
   The doctor carefully inspects the shape of the feet, toes, hands, and spine. High arches, hammertoes, thin calves, and wasting of hand muscles strongly suggest a long-standing neuropathy such as CMT. The presence of symmetrical deformities and family history supports a genetic cause like GARS1 mutation. Wikipedia+1

3. Gait and posture assessment
   Observing how a person walks is a simple but powerful test. The doctor looks for foot drop, steppage gait, wide-based walking, or unsteadiness when turning. They may also ask the person to walk on heels or toes and to stand on one leg. These tasks reveal subtle weakness and balance problems typical of CMT2. Europe PMC+1

4. Family history and pedigree analysis
   Taking a careful family history acts as a diagnostic “test” for inheritance pattern. The physician asks about relatives with similar foot deformities, walking difficulties, or diagnosed neuropathy. Drawing a three-generation family tree can show an autosomal dominant pattern, which strongly suggests a hereditary neuropathy like GARS1-related CMT2D. NCBI+1

Manual bedside tests

5. Manual muscle testing (MRC grading)
   Using their hands, the examiner grades muscle strength on a standard scale, often the Medical Research Council (MRC) scale from 0 to 5. In CMT2D, distal muscles in hands and feet show lower grades before proximal muscles. This pattern helps confirm that the weakness is length-dependent and compatible with axonal neuropathy. Europe PMC+1

6. Sensory testing (light touch, pinprick, temperature)
   Simple tools, such as cotton wisp, pin, and tuning fork, are used at the bedside to test sensation. The doctor checks whether the patient feels touch and pain normally on toes, feet, fingers, and hands. Mild loss of vibration or pinprick in a stocking-and-glove pattern supports the diagnosis of a length-dependent neuropathy like CMT2D. Europe PMC+1

7. Deep tendon reflex testing
   The clinician taps the Achilles, knee, and upper limb tendons with a reflex hammer. In many people with CMT2D, ankle reflexes are absent and knee reflexes may be reduced, while upper limb reflexes can also be weak. This symmetrical reduction in reflexes fits a diffuse polyneuropathy rather than a problem restricted to the spinal cord. MalaCards+1

8. Romberg and balance tests
   The Romberg test asks the patient to stand with feet together and then close their eyes. Increased swaying or loss of balance suggests impaired proprioception, which can occur when sensory nerves are affected. Other balance tests, such as tandem walking (heel-to-toe), also help reveal subtle instability due to neuropathy. Europe PMC+1

9. Functional hand assessments
   Clinicians may observe or time tasks such as buttoning clothes, writing, placing pegs in a board, or picking up small objects. Slowness and difficulty performing these fine tasks highlight distal hand weakness and are characteristic of GARS1-related neuropathy, where hand involvement is often early and prominent. NCBI+1

Laboratory and pathological studies

10. Basic blood tests to rule out acquired neuropathies
    Although blood tests do not diagnose CMT2D directly, they are essential to exclude other causes of neuropathy. Doctors often check blood sugar, vitamin B12, thyroid function, kidney and liver tests, and sometimes immune markers. Normal results support a hereditary cause like GARS1 mutation, while abnormal results may point to a different or additional problem. Europe PMC+1

11. Genetic testing panel for CMT including GARS1 sequencing
    The key laboratory test is molecular genetic analysis. Many laboratories offer multigene panels for Charcot-Marie-Tooth disease that include GARS1 among many other genes. Sequencing identifies pathogenic variants, and confirming a GARS1 mutation firmly establishes the diagnosis of GARS-related CMT2D or dHMN-V. NCBI+2NCBI+2

12. Targeted family mutation testing
    Once the disease-causing GARS1 variant is known in one family member (the proband), other at-risk relatives can be tested for that same variant. This targeted test is faster and cheaper than broad sequencing. It helps clarify who carries the mutation, who is likely to develop symptoms, and who can pass the mutation to children. NCBI+1

13. Nerve biopsy (usually sural nerve) in unclear cases
    In rare, unclear situations, doctors may take a small piece of a sensory nerve near the ankle (sural nerve biopsy) to examine under the microscope. In axonal CMT like CMT2D, the biopsy typically shows loss of large myelinated fibers without the onion-bulb formations seen in demyelinating forms. Today, biopsy is used less often because genetic testing is widely available. Europe PMC+1

14. Cerebrospinal fluid (CSF) analysis
    A lumbar puncture can be done when an inflammatory neuropathy is suspected. In hereditary neuropathies such as GARS1-related CMT2D, CSF protein is usually normal or only slightly raised. A strongly elevated CSF protein or presence of inflammatory cells would suggest an acquired immune neuropathy rather than pure genetic CMT. Europe PMC+1

Electrodiagnostic studies

15. Nerve conduction studies (NCS)
    Nerve conduction studies measure how fast and how strongly electrical signals travel in peripheral nerves. In CMT2D, motor and sensory responses are often reduced in size (low amplitudes) but conduction speeds are relatively preserved, which is typical for an axonal neuropathy. This pattern helps distinguish CMT2 from demyelinating forms like CMT1. Europe PMC+1

16. Electromyography (EMG)
    EMG uses a small needle electrode to record electrical activity inside muscles. In CMT2D, EMG usually shows signs of chronic denervation, such as large motor units and reduced recruitment. These findings confirm that the problem lies in the motor neurons or their axons rather than in the muscle itself. Europe PMC+1

17. F-wave and late response studies
    F-waves are late responses generated by sending signals back and forth along motor nerves. In axonal neuropathies, F-waves may be absent or show reduced persistence. Studying these late responses helps assess the entire length of the motor nerve and can reveal diffuse axonal involvement even when routine conduction velocities are near normal. Europe PMC+1

18. Somatosensory evoked potentials (SSEPs)
    Somatosensory evoked potentials test the function of sensory pathways from the limb to the brain by recording responses to small electrical stimuli. In patients with significant sensory involvement, SSEPs may be delayed or reduced. Although not always needed, SSEPs can help assess central and peripheral contributions to sensory symptoms in complex cases. Europe PMC+1

Imaging studies

19. Magnetic resonance imaging (MRI) of spine and plexus
    MRI does not directly diagnose CMT2D, but it is useful to rule out other causes of weakness, such as spinal cord compression or nerve root problems. In some cases, MRI of limb muscles may show a pattern of fatty replacement and atrophy in distal muscles, which supports long-standing neuropathy and helps guide management and rehabilitation planning. Europe PMC+1

20. X-rays or MRI of feet and ankles
    Plain X-rays of the feet can show high arches, hammertoes, and other skeletal deformities linked with CMT. MRI can give more detail about muscle bulk, joint alignment, and tendon position. These imaging tests are particularly useful for orthopedic planning, such as choosing braces or considering corrective surgery to improve walking and reduce pain. Wikipedia+1

Non-pharmacological treatments (therapies and others)

Below are 20 non-drug treatments commonly used for Charcot-Marie-Tooth disease, including CMT2 due to GARS mutation. They do not cure the disease, but they can greatly improve function, comfort, and quality of life.Physiopedia+2Mayo Clinic+2

1. Physical therapy and stretching
Physical therapy is a core treatment. The therapist teaches gentle stretching and movement exercises that keep joints flexible and muscles as long as possible. Regular stretching of calf, hamstring, and hand muscles helps prevent contractures, which are painful permanent tightening of muscles and tendons. The purpose is to maintain range of motion, reduce stiffness, and protect walking ability. The main mechanism is repeated slow stretching that remodels soft tissues and keeps tendons and muscles from shortening.nhs.uk+1

2. Strength and resistance training
Carefully planned strength training can help preserve remaining muscle power in legs and hands without overworking weak muscles. Light weights, resistance bands, or body-weight exercises are used in short sessions. The purpose is to maintain muscle mass and delay weakness. The mechanism is progressive overload: small, controlled stress on surviving muscle fibers and motor units stimulates them to stay active and strong, while the therapist avoids fatigue that might worsen symptoms.Physiopedia+1

3. Balance and gait training
Because CMT damages sensory nerves and small muscles in the feet, many people have poor balance and frequent tripping. In balance training, therapists use standing exercises, heel-to-toe walking, and safe obstacle courses to improve coordination. The purpose is to reduce falls. The mechanism is neuroplasticity: repeated practice helps the brain use visual cues and remaining sensory input more efficiently and strengthens postural muscles that stabilize the body during walking.PMC+1

4. Ankle-foot orthoses (AFOs)
AFOs are light plastic or carbon-fiber braces that hold the ankle at a right angle and prevent the toes from dropping during walking. People often use them when foot drop becomes obvious. The purpose is to improve safety, walking speed, and energy use. Mechanically, the brace keeps the ankle stable, lifts the toes during swing phase, and reduces the need for awkward high-stepping compensations, lowering the risk of tripping.Mayo Clinic+1

5. Custom shoes and foot orthotics
Orthotists can design custom shoes, insoles, or arch supports for high-arched feet and hammer toes, which are common in CMT. The purpose is to distribute weight more evenly across the sole, reduce pressure points, and improve alignment. The mechanism is simple biomechanics: reshaping the contact surface between foot and ground helps correct abnormal loading, reduces pain, and may slow worsening deformity.Mayo Clinic+1

6. Hand splints and adaptive devices
Hand weakness in GARS-related CMT often affects fine tasks. Occupational therapists can provide thumb and wrist splints, built-up pens, special cutlery, zipper pulls, and button hooks. The purpose is to keep people independent in writing, eating, and dressing. The mechanism is mechanical support for weak joints combined with clever design of tools so that tasks need less grip strength and less finger control.PMC+1

7. Occupational therapy for daily activities
Occupational therapy focuses on practical skills such as dressing, bathing, computer use, and cooking. The therapist analyzes each task and suggests easier ways to do it, or equipment to help. The purpose is to protect joints and conserve energy while keeping independence. The mechanism is activity modification: changing posture, using both hands, or rearranging the home to reduce the strain on weak muscles and unstable ankles.PMC+1

8. Aerobic exercise and conditioning
Low-impact aerobic activities such as walking on flat ground, cycling, or swimming are often recommended. The purpose is to keep heart and lungs healthy, reduce fatigue, improve mood, and prevent weight gain, which would stress weak ankles and knees. The mechanism is improved cardiovascular fitness and better oxygen delivery to muscles, which can increase overall stamina even though the underlying nerve damage remains.Physiopedia+1

9. Hydrotherapy and swimming
Water-based therapy uses the buoyancy of water to support the body while exercising. In a pool, people can practice walking, gentle resistance movements, and stretching with less risk of falling. The purpose is safe strengthening and improved mobility. The mechanism is reduced joint loading and natural resistance from water, which lets weak muscles work without sudden impacts or heavy strain.Physiopedia+1

10. Mobility aids (canes, crutches, walkers, wheelchairs)
Some people with CMT2 eventually need walking aids or, later, a wheelchair for long distances. The purpose is to prevent falls, decrease pain, and allow safe participation at school, work, and in the community. The mechanism is weight sharing: canes and walkers take part of the body weight that would otherwise overload weak calves and unstable ankles, while a wheelchair can conserve energy on long outings.PMC+1

11. Fall-prevention and home modifications
Simple changes at home, such as removing loose rugs, adding grab bars, using night lights, and rearranging furniture, can greatly reduce fall risk. The purpose is to create a safe environment that matches the person’s balance and strength. The mechanism is hazard reduction: by eliminating trip points and making handholds available, the person is less likely to fall even with foot drop and poor sensation.PMC+1

12. Pain psychology and cognitive-behavioural therapy (CBT)
Chronic nerve pain and disability can cause anxiety, low mood, and sleep problems. Pain psychologists use CBT and other talking therapies to teach coping skills, relaxation, and pacing. The purpose is to reduce the suffering caused by pain and disability, even if the physical sensation does not fully go away. The mechanism is changing thoughts and behaviours around pain, which can reduce central sensitization and improve quality of life.PMC+1

13. Mental health counselling and support groups
Living with a progressive genetic disease is emotionally hard. Individual counselling and patient support groups give space to share feelings, learn from others, and reduce isolation. The purpose is emotional resilience and realistic hope. The mechanism is social support and better coping strategies, which are known to protect mental health in chronic illnesses.PMC+1

14. Genetic counselling for patients and families
Because GARS-related CMT is inherited, genetic counselling helps families understand inheritance patterns, testing options, and reproductive choices. The purpose is informed decision-making and reduced guilt or confusion. The mechanism is clear education about autosomal dominant transmission, recurrence risks, and available testing for relatives who may be at risk.NCBI+1

15. Education on joint protection and energy conservation
Therapists teach people to avoid heavy lifting, sudden twisting, or standing for very long periods, and to break tasks into smaller steps with rest breaks. The purpose is to reduce overuse injuries and daily fatigue. The mechanism is load management: by avoiding repetitive stress on weak joints and muscles, inflammation, pain, and micro-trauma are minimized.PMC+1

16. Vocational and school rehabilitation
Specialists can help adapt school or work tasks, suggest ergonomic equipment, or assist in choosing careers that fit physical abilities. The purpose is to keep people in education and employment for as long as possible. The mechanism is task redesign and workplace accommodations, which reduce physical barriers and support long-term participation.PMC+1

17. Nutritional counselling to maintain healthy weight
Dietitians advise on balanced eating to avoid both under-nutrition and obesity. The purpose is to provide enough energy and nutrients for nerve and muscle health without extra body weight that can stress weak feet and ankles. The mechanism is optimized calorie and nutrient intake, which supports general health and reduces mechanical load on the musculoskeletal system.PMC+1

18. Orthopaedic monitoring of foot and spine
Regular review by an orthopaedic specialist helps track progression of foot deformities, scoliosis, or hip/knee problems. The purpose is early detection of structural issues that might be helped with braces or surgery. The mechanism is surveillance: catching problems early gives more conservative options and better long-term outcomes.Mayo Clinic+1

19. Respiratory and sleep assessment (when needed)
In advanced or severe cases, some people may develop breathing or sleep problems, especially if there is weakness of chest muscles or coexisting scoliosis. Sleep studies and pulmonary tests can identify issues. The purpose is to prevent unrecognized nocturnal hypoventilation and fatigue. The mechanism is early detection and management with non-invasive ventilation or other support when indicated.PMC+1

20. Regular follow-up in a neuromuscular clinic
Because CMT2D is lifelong and slowly progressive, regular check-ups allow the team to adjust braces, change therapy goals, and manage new symptoms. The purpose is continuous, proactive care rather than crisis-based care. The mechanism is periodic comprehensive review, which picks up subtle changes early and coordinates different specialists around the patient’s needs.PMC+1

---

Drug treatments

There is no medicine approved specifically to cure or reverse GARS-related CMT2. Drug treatment mainly targets neuropathic pain, muscle cramps, mood problems, and sleep issues. Many of the medicines below are approved by the FDA for other neuropathic pain conditions, such as diabetic neuropathy or postherpetic neuralgia, and are sometimes used off-label in CMT after careful discussion with a doctor.PMC+2GMMMG+2

Because you are a teenager, dose and safety must always be decided by a neurologist or pain specialist. The short descriptions below are based on FDA labels and neuropathic pain guidelines.GMMMG+3FDA Access Data+3FDA Access Data+3

1. Pregabalin (Lyrica)
Pregabalin is an anti-seizure medicine widely used for nerve pain. The FDA label lists indications such as neuropathic pain in diabetic neuropathy and postherpetic neuralgia.FDA Access Data+1 Doctors may use similar dosing schedules for painful neuropathy in CMT, starting with a low dose once or twice daily and slowly increasing. It reduces pain by binding to calcium channels on nerve endings, lowering the release of pain-signalling chemicals like glutamate. Common side effects include dizziness, sleepiness, weight gain, and swelling in the legs.

2. Gabapentin (Neurontin, Gralise, Horizant)
Gabapentin is another anti-seizure medicine approved for postherpetic neuralgia and as adjunct therapy in some seizures.FDA Access Data+3FDA Access Data+3FDA Access Data+3 It is often used off-label as first-line or second-line treatment for neuropathic pain in adults. Doctors usually start with a small dose at night and gradually raise it to a total dose divided through the day. Gabapentin reduces abnormal excitability in pain pathways. Frequent side effects are drowsiness, dizziness, and coordination problems, so it must be increased slowly.

3. Duloxetine (Cymbalta)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant. The FDA label includes indications for diabetic neuropathic pain, depression, and generalized anxiety disorder.FDA Access Data+2FDA Access Data+2 In neuropathic pain, it is usually given once or twice a day at doses prescribed by the doctor. Duloxetine works by boosting serotonin and noradrenaline in pain-modulating pathways in the spinal cord and brain. Side effects can include nausea, dry mouth, sweating, raised blood pressure, and sometimes sleep disturbance.

4. Amitriptyline (tricyclic antidepressant)
Amitriptyline is an older antidepressant that is commonly used at low doses to treat nerve pain, even though this use may be off-label.South East London ICS+3PMC+3nhs.uk+3 It is usually taken once at night because it can cause drowsiness. It works by blocking reuptake of serotonin and noradrenaline and also by sodium-channel effects in pain fibers. Side effects may include dry mouth, constipation, blurred vision, weight gain, and heart rhythm changes, so ECG monitoring is sometimes needed in adults.

5. Nortriptyline (tricyclic antidepressant)
Nortriptyline is related to amitriptyline but tends to have slightly fewer sedating and anticholinergic side effects. Neuropathic pain guidelines often list it as an alternative if amitriptyline is effective but not tolerated.GMMMG+1 It is usually taken at night in low doses and slowly increased. The purpose is long-term pain control. Its mechanism is similar to that of amitriptyline, enhancing descending inhibitory pathways that dampen pain signals.

6. Topical lidocaine 5% patch (Lidoderm and generics)
Lidocaine 5% patches are FDA-approved for pain after shingles (postherpetic neuralgia).FDA Access Data+2FDA Access Data+2 In some neuropathic conditions with localized pain, doctors may place patches on the most painful area of skin for limited hours per day. The purpose is local pain relief with minimal whole-body effects. Lidocaine blocks sodium channels in superficial nerve endings so they cannot fire pain signals. Side effects are usually mild skin irritation, but overdose or misuse can cause serious toxicity, so instructions must be followed carefully.

7. Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs such as ibuprofen or naproxen do not treat nerve damage but can help with musculoskeletal pain from overworked joints, ankle sprains, or post-surgical pain. They work by blocking cyclo-oxygenase enzymes and reducing prostaglandin production, which lowers inflammation and pain. Side effects include stomach irritation, bleeding risk, and kidney strain, especially at higher doses or with long-term use, so they must be used under medical advice.PMC+1

8. Baclofen (oral muscle relaxant)
Baclofen is approved for spasticity in multiple sclerosis and spinal cord injury.FDA Access Data+2FDA Access Data+2 In some neuromuscular conditions, doctors may use it off-label to reduce troublesome muscle cramps or stiffness. It activates GABA-B receptors in the spinal cord, reducing muscle overactivity. Doses must be increased gradually to avoid side effects such as drowsiness, weakness, or confusion, and it must not be stopped suddenly because of withdrawal reactions.

9. Short-term opioids or tramadol (in selected cases)
In severe acute pain, for example after orthopaedic surgery, doctors sometimes use opioids or tramadol for a short period. They attach to opioid receptors in the central nervous system to reduce the perception of pain. Because of risks of dependence, constipation, drowsiness, breathing depression, and overdose, guidelines recommend only brief use at the lowest effective dose, and they are rarely a long-term solution for CMT-related pain.GMMMG+1

10. Sleep medicines and anxiety treatments
Chronic pain and disability can hurt sleep and mood. In some cases, doctors prescribe medicines for insomnia or anxiety, such as certain non-benzodiazepine hypnotics or SSRIs/SNRIs. These do not treat the nerve damage but may break the cycle of pain, poor sleep, and emotional distress. The mechanism is calming overactive brain circuits and improving sleep architecture, which can indirectly reduce pain sensitivity and fatigue. Because of side effects and dependence risks, these drugs need careful specialist supervision.PMC+1

(Other drug options, such as carbamazepine, oxcarbazepine, or combination treatments, may be considered by pain specialists based on individual response and side-effect profiles, but they are not specifically approved for GARS-related CMT.)GMMMG+1

---

Dietary molecular supplements

Evidence for supplements in CMT, especially GARS-related CMT2, is limited and mostly indirect, coming from studies in other neuropathies or general nerve health. Always discuss supplements with a doctor or dietitian, especially if you already take prescription drugs.PMC+1

1. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant that has been studied in diabetic neuropathy, where it may slightly improve pain and numbness. It seems to work by reducing oxidative stress in nerve cells and improving blood flow to nerves. Typical adult supplement doses in studies have been in the hundreds of milligrams per day, but exact dosing for CMT is not established. Possible side effects include stomach upset and low blood sugar, so medical supervision is needed.PMC+1

2. Acetyl-L-carnitine
Acetyl-L-carnitine is involved in energy production inside mitochondria. Some small studies in chemotherapy-induced neuropathy suggest it may help nerve repair and reduce pain. The proposed mechanism is improved fatty-acid transport into mitochondria and neurotrophic effects that support axon regeneration. Doses used in trials have varied widely, and long-term safety is still being studied. People with seizure disorders or thyroid problems must be especially cautious.PMC+1

3. Coenzyme Q10 (CoQ10)
CoQ10 is another mitochondrial co-factor and antioxidant. It helps in the electron transport chain and ATP production. In theory, improving mitochondrial function may support stressed nerve cells in hereditary neuropathies, though specific data in GARS-related CMT are lacking. Typical supplement doses for other conditions range from tens to hundreds of milligrams per day. Side effects are usually mild, such as stomach discomfort.PMC+1

4. Omega-3 fatty acids (fish oil)
Omega-3 fatty acids, especially EPA and DHA from fish oil, have anti-inflammatory and membrane-stabilizing properties. They can be incorporated into nerve cell membranes and may reduce inflammatory signalling. In general neurology, omega-3s are often recommended to support cardiovascular and brain health. Doses vary, and high doses may increase bleeding risk, especially with blood-thinning medicines.PMC+1

5. Vitamin D
Vitamin D is important for bone health, immune regulation, and muscle function. Low vitamin D is common in people with limited mobility or little sun exposure. Correcting deficiency can help bone strength and possibly muscle performance, which is important in people with weak ankles and a high fall risk. Dose depends on blood levels measured by a doctor; too much vitamin D can cause high calcium and kidney damage.PMC+1

6. B-vitamin complex (B1, B6, B12)
B-vitamins are essential for normal nerve function and myelin formation. Severe deficiency of B1 or B12 can cause neuropathy on its own. In GARS-related CMT, they do not cure the genetic problem but can prevent additional, avoidable damage. The mechanism is co-factor roles in energy metabolism and myelin synthesis. Excess B6 can itself cause neuropathy, so doses must stay within medical advice.PMC+1

7. Magnesium
Magnesium supports muscle relaxation and nerve conduction. Some people use it to help with muscle cramps or restless legs, although evidence is mixed. Mechanistically, magnesium influences NMDA receptors and muscle membrane stability. Too much magnesium, especially in kidney disease, can be dangerous, so supplementing should be guided by a clinician.PMC+1

8. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant effects in laboratory studies. In theory, it may reduce low-grade inflammation around nerves and muscles. It is usually taken in special formulations that increase absorption. Because it can interact with blood thinners and other drugs, it should be used cautiously. High-quality clinical evidence in CMT is still lacking.PMC+1

9. Vitamin C
Vitamin C is an antioxidant and important for collagen production in connective tissues. Earlier research in CMT1A tested high doses of ascorbic acid but did not show strong clinical benefit; still, maintaining a normal dietary intake supports general tissue repair. The mechanism is free-radical scavenging and co-factor roles in collagen synthesis. Large supplement doses can cause stomach upset and kidney stones in susceptible people.American Academy of Neurology+1

10. Probiotics and gut-health supplements
A healthy gut microbiome may support immune balance and nutrient absorption. Some people use probiotic supplements or fermented foods to improve digestion and wellbeing. For CMT2D, this is indirect support rather than targeted nerve treatment. The mechanism is modulation of gut bacteria that may influence inflammation and metabolism. Safety is generally good in healthy people but must be checked in those with severe immune problems.PMC+1

---

Regenerative, stem-cell and immunity booster drugs

At present, there are no FDA-approved stem-cell or regenerative drugs specifically for Charcot-Marie-Tooth disease type 2 caused by GARS mutation. Research is active, especially in other CMT subtypes, but these approaches remain experimental and are usually offered only in clinical trials.PMC+2Wiley Online Library+2

Scientists are studying:

1. Gene therapy approaches (e.g., AAV1.NT-3)
In some CMT forms, gene therapy using viral vectors carrying neurotrophin-3 (NT-3) has shown benefit in animal models and early human studies, improving myelination and nerve regeneration.American Academy of Neurology+3PMC+3ClinicalTrials.gov+3 The mechanism is delivering a healthy gene that boosts growth factors in Schwann cells and nerves. However, these trials currently target mainly demyelinating CMT1A or CMT4, not GARS-related CMT2, and are highly specialized research treatments.

2. Combination disease-modifying drugs (e.g., PXT3003 in CMT1A)
PXT3003, a combination of baclofen, naltrexone, and D-sorbitol, is being studied in phase III trials for CMT1A as a disease-modifying therapy.CenterWatch+3ClinicalTrials.gov+3Institut Myologie+3 It aims to correct overexpression of PMP22 and improve Schwann cell function. Although promising for CMT1A, it is not approved yet and has not been proven for GARS-related CMT2.

3. Experimental stem-cell strategies
Researchers are exploring stem-cell transplants and cell-based therapies in various peripheral neuropathies, trying to support regeneration of myelin and axons. So far, evidence is mostly from animal work or early small human studies, and no specific stem-cell drug has FDA approval for any CMT subtype.Wiley Online Library+1

For now, the safest approach is to join registered clinical trials through academic centers rather than private “stem-cell clinics,” which may be expensive and risky. Your neurologist can advise whether any trial is suitable.

---

Surgical treatments

Surgery does not fix the nerve damage, but it can correct bone and joint deformities that develop due to long-term muscle imbalance in CMT. Decisions are individual and require careful discussion with an experienced orthopaedic surgeon.Mayo Clinic+2PMC+2

1. Foot deformity correction (osteotomy)
High-arched feet (pes cavus), claw toes, and heel tilting can cause pain and recurrent ankle sprains. Surgeons may cut and realign bones in the foot (osteotomy), sometimes with tendon transfers, to rebalance forces. The purpose is to create a more stable, plantigrade foot that fits better in shoes and braces. Mechanically, realignment distributes load more evenly and improves gait.

2. Tendon transfer procedures
In tendon transfer surgery, a stronger tendon is moved to replace the function of a weaker tendon around the ankle or foot. For example, a tendon that lifts the foot may be strengthened using a different muscle. The purpose is to improve active control of the foot and reduce foot drop. The mechanism is redirecting muscle force to restore more balanced movement across joints.

3. Joint fusion (arthrodesis)
In severe deformities or painful, unstable joints, surgeons may permanently fuse certain joints in the foot or ankle. This removes motion at the joint but can greatly improve stability and pain. The purpose is a solid, pain-free base for walking. The mechanism is eliminating abnormal motion that stresses surrounding tissues.

4. Correction of scoliosis or other skeletal deformities
Some people with hereditary neuropathies develop scoliosis or other skeletal problems. In significant cases, spinal surgery may be needed to prevent progression or to improve breathing and posture. The mechanism is mechanical correction with rods and screws to stabilize the spine.

5. Post-operative rehabilitation
Surgery is only the start. Careful rehabilitation with physical therapy, new braces, and gait retraining is essential afterward. The purpose is to maximize the benefit from the structural correction and avoid complications. The mechanism is progressive weight-bearing, muscle strengthening, and learning new movement patterns with the corrected anatomy.Mayo Clinic+1

---

Prevention and lifestyle protection

You cannot prevent the genetic mutation, but you can reduce complications and slow functional decline. Here are ten practical prevention strategies:PMC+2PMC+2

1. Avoid smoking, which harms blood vessels and reduces oxygen supply to nerves and muscles.

2. Keep a healthy body weight to reduce stress on weak ankles, knees, and hips.

3. Use braces and orthotics as prescribed to limit falls and joint injuries.

4. Do regular, gentle exercise to maintain strength, balance, and heart health.

5. Protect your feet, wearing well-fitting shoes, checking skin daily, and treating small wounds early.

6. Avoid extreme heat or cold exposure, which can worsen numbness and skin damage.

7. Practice safe lifting and posture, avoiding heavy loads and twisting movements that strain weak muscles.

8. Stay up to date with vaccinations, to reduce risk of infections that could worsen weakness or require long bed rest.

9. Manage other health conditions such as diabetes or thyroid disease carefully, as they can add extra nerve damage.

10. Attend regular neuromuscular check-ups, so problems are detected early and treatments adjusted in time.

---

When to see a doctor

You should see a neurologist or your usual doctor promptly if you notice:

• New or rapidly worsening weakness in hands or feet.

• Sudden increase in falls, tripping, or difficulty climbing stairs.

• New severe pain, burning, electric shocks, or cramps that interfere with sleep.

• Ulcers, infections, or colour changes in the feet that do not heal quickly.

• Breathing difficulty, morning headaches, or severe snoring that could signal sleep-related breathing problems.

• Worsening curvature of the spine, hip problems, or new joint deformities.

• Mood changes, anxiety, or low mood that makes daily life very hard.

Emergency care is needed if there is sudden inability to walk, severe breathing trouble, chest pain, or confusion.

---

What to eat and what to avoid

Diet for CMT2D is about general nerve and muscle health, weight control, and heart protection.PMC+1

Helpful foods (what to eat)

1. Plenty of vegetables and fruits for vitamins, minerals, and antioxidants that support tissue repair.

2. Whole grains such as brown rice, oats, and whole-wheat bread to provide steady energy and fibre.

3. Lean protein (fish, poultry, beans, lentils, eggs) to build and maintain muscle.

4. Healthy fats from nuts, seeds, olive oil, and oily fish (omega-3s) to support cell membranes and reduce inflammation.

5. Low-fat dairy or fortified alternatives for calcium and vitamin D to protect bones.

Foods and habits to limit or avoid

1. Sugary drinks and sweets, which add empty calories and promote weight gain.

2. Highly processed fast foods rich in saturated fat, trans fat, and salt that harm heart and blood vessels.

3. Excess caffeine and energy drinks, which can disturb sleep and worsen anxiety.

4. Alcohol, which in high amounts can directly damage nerves and interact with medicines.

5. Crash diets or extreme restriction, which may cause nutrient deficiencies and weaken muscles further.

A dietitian can help design a meal plan suited to age, activity level, and any other medical conditions.

---

FAQs

1. Is GARS-related CMT2D the same as “classic” CMT?
It belongs to the same big family of Charcot-Marie-Tooth diseases but has some special features. GARS1-related neuropathy is an axonal form (type 2), often starting in the hands with weakness of finger and thumb muscles, whereas many common CMT1 forms start in the legs.NCBI+1

2. How is GARS-related CMT diagnosed?
Doctors first look at symptoms, family history, and nerve conduction studies that show an axonal neuropathy. Genetic testing then looks specifically for pathogenic variants in the GARS1 gene to confirm the diagnosis.NCBI+1

3. Can this disease be cured?
At the moment there is no cure that removes or repairs the GARS mutation in humans. Treatment is supportive, aiming to keep people walking, using their hands, and staying independent as long as possible. Research into gene and cell therapies is ongoing.PMC+2Wiley Online Library+2

4. Will everyone with the mutation have the same severity?
No. Even in the same family, some people may have very mild weakness while others need braces or surgery. This variation likely comes from other genes, lifestyle, and random biological factors.NCBI+1

5. Does exercise make the disease worse?
Appropriate, low-impact, supervised exercise usually helps rather than harms. Over-fatiguing very weak muscles can cause soreness, but carefully designed physical therapy and aerobic activity are recommended to maintain function.Physiopedia+1

6. Can children with GARS-related CMT play sports?
Many children can take part in adapted sports or less intense activities. The key is safety: avoiding high-impact contact sports with a high fall risk, using braces if needed, and listening to pain and fatigue signals. A paediatric neurologist and therapist can guide choices.PMC+1

7. Is pregnancy safe for someone with CMT2D?
Many people with CMT have healthy pregnancies. However, extra weight and hormonal changes can worsen balance and foot problems. Obstetric and neuromuscular teams should plan care together, and there is a 50% chance of passing an autosomal dominant mutation to each child.NCBI+1

8. Are high-heel shoes okay to wear?
High heels increase ankle instability and fall risk in people with weak ankles and high arches, so they are usually discouraged. Supportive, flat shoes with good grip and enough room for orthotics are safer choices.Mayo Clinic+1

9. Do supplements replace medicines or therapy?
No. Supplements can sometimes support general health but do not replace braces, surgery, or evidence-based pain medicines. They should be seen as optional add-ons and always discussed with the care team to avoid interactions.PMC+1

10. Can people with CMT2D live a normal lifespan?
Most people with CMT, including many with GARS-related forms, have a near-normal life expectancy, though they may have physical disability. Good management of falls, infections, and general health is important to stay well.PMC+1

11. Is gene therapy close to being available?
Gene therapy trials are advancing in some CMT subtypes like CMT1A and CMT4C, but none are yet approved for routine care. For GARS-related CMT2D, research is at an even earlier stage. It is promising but still experimental.AFM Téléthon+3PMC+3ClinicalTrials.gov+3

12. Should family members be tested?
Genetic counselling can help relatives decide. Testing may be helpful for family planning or early monitoring, but not everyone wants this information. The decision should be personal and well-informed.NCBI+1

13. Why do some people need surgery while others do not?
Surgery is usually reserved for people with severe deformities that cause pain or make walking very hard. If braces and therapy control symptoms well, surgery may not be needed. The pattern and speed of deformity vary widely between individuals.Mayo Clinic+1

14. Are there medicines that should be avoided?
Some drugs are known to be toxic to peripheral nerves (for example, some chemotherapy agents) and must be used with great caution in anyone with neuropathy. If you ever need new medicines, tell your doctors that you have hereditary neuropathy so they can check for nerve-toxic drugs.PMC+1

15. What is the most important message for daily life with GARS-related CMT2D?
The key message is that while the gene change cannot yet be fixed, many things can be done to protect function: use braces early, keep muscles and joints moving with safe exercise, prevent falls, manage pain properly, look after mental health, and stay in regular contact with a neuromuscular team. Over time, these steps can make a very big difference in comfort, mobility, and independence.PMC+2PMC+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 29, 2025.